Regenexx are competitors. The difference is that they inject the patient with his own stem cells. This process is not FDA approved. In fact Regenexx are in fighting the FDA, on the basis that it is a surgical procedure and therefore not an FDA issue. So there has not been any trials that prove their assertions about efficacy. In fact you will find very little authoritive unbiased imformation about Regenexx. So they have a vested interest in baggging MSB. Never the less, I would like a clinician to evaluate the article by them.
- Forums
- ASX - By Stock
- credible critique or not?
Regenexx are competitors. The difference is that they inject the...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.33 |
Change
0.045(3.50%) |
Mkt cap ! $1.518B |
Open | High | Low | Value | Volume |
$1.30 | $1.35 | $1.30 | $2.885M | 2.183M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 15000 | $1.32 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.33 | 7070 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15000 | 1.320 |
4 | 52476 | 1.315 |
2 | 38920 | 1.310 |
2 | 36000 | 1.305 |
4 | 41291 | 1.300 |
Price($) | Vol. | No. |
---|---|---|
1.330 | 7070 | 1 |
1.335 | 20000 | 1 |
1.340 | 19777 | 4 |
1.345 | 90791 | 6 |
1.350 | 36184 | 3 |
Last trade - 16.10pm 06/11/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |